Methods and means for efficient skipping of exon 45 in Duchenne Muscular Dystrophy pre-mRNA

Details for Australian Patent Application No. 2009310557 (hide)

Owner Academisch Ziekenhuis Leiden Prosensa B.V. Prosensa Technologies B.V. Prosensa Holding BV

Inventors De Kimpe, Josephus Johannes; Platenburg, Gerard Johannes; Van Deutekom, Judith Christina Theodora; Aartsma-Rus, Annemieke; Van Ommen, Garrit-Jan Boudewijn

Agent Griffith Hack

Pub. Number AU-A-2009310557

PCT Pub. Number WO2010/050801

Priority PCT/ NL2008/050673 27.10.08 NL

Filing date 13 January 2009

Wipo publication date 6 May 2010

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

Event Publications

19 May 2011 PCT application entered the National Phase

  PCT publication WO2010/050801 Priority application(s): WO2010/050801

29 September 2011 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Academisch Ziekenhuis Leiden, Prosensa B.V., Prosensa Technologies B.V., Prosensa Holding BV, Application No. 2009310557. under INID (72) correct the co-inventor to Platenburg, Gerardus Johannes

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009310558-Methods and means for efficient skipping of at least one of the following exons of the human Duchenne muscular dystrophy gene: 43, 46, 5053.

2009310547-Conditional processing method and apparatus